Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer

Increasing evidence suggests that long non-coding riboneucleic acids (lncRNAs), as competing endogenous RNA (ceRNA), play a key role in the initiation, invasion, and metastasis of cancer. As a new hypothesis, the lncRNA-micro RNA (miRNA)-messenger RNA (mRNA), ceRNA regulatory network has been successfully constructed in a variety of cancers. However, lncRNA, which plays a ceRNA function in endometrial cancer (EC), is still poorly understood. In this study, we downloaded EC expression profiling from The Cancer Genome Atlas database and used the R software “edgeR” package to analyze the differentially expressed genes between EC and normal endometrium samples. Then, differentially expressed (DE) lncRNAs, miRNAs and mRNAs were selected to construct a lncRNA-miRNA-mRNA prognosis-related regulatory network based on interaction information. The Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed on the genes in the network to predict the potential underlying mechanisms and functions of lncRNAs in EC. Kaplan–Meier method and the log-rank test were used for survival analysis. Based on the “ceRNA hypothesis,” we constructed a co-expression network of mRNA and lncRNA genes mediated by miRNA in the process of tumor genesis. Furthermore, we successfully constructed a dysregulated lncRNA-associated ceRNA network containing 96 DElncRNAs, 27 DEmiRNAs, and 74 DEmRNAs. Through Kaplan–Meier curve analysis, we found that 9 lncRNAs, 3 miRNAs, and 12 mRNAs were significantly correlated with the overall survival rate of patients among all lncRNAs, miRNAs, and mRNAs involved in ceRNA (P < .05). Our research provides a new perspective for the interaction among lncRNAs, miRNAs, and mRNA and lays the foundation for further research on the mechanism of lncRNAs in the occurrence of EC.

[1]  W. Cao,et al.  A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients , 2022, Frontiers in Immunology.

[2]  A. Dmitriev,et al.  Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs , 2022, International journal of molecular sciences.

[3]  Yijun Shi,et al.  Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis , 2022, Frontiers in Oncology.

[4]  Shiwei Duan,et al.  Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis , 2022, Biomarker Research.

[5]  J. Lizcano,et al.  The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival , 2022, bioRxiv.

[6]  T. Niki,et al.  ZEB1 expression is frequently detected in undifferentiated and de‐differentiated carcinomas, but is not specific among endometrial carcinomas , 2022, Histopathology.

[7]  J. McAlpine,et al.  Endometrial cancer , 2022, The Lancet.

[8]  P. Wang,et al.  Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma , 2022, Aging.

[9]  R. Tsutsumi,et al.  LncRNA–miRNA–mRNA regulatory axes in endometrial cancer: a comprehensive overview , 2022, Archives of Gynecology and Obstetrics.

[10]  P. Wang,et al.  Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines , 2021, Cells.

[11]  Liana J Goehring,et al.  WEE1i-ATRi combination therapy: a promising low-dose treatment for CCNE1-amplified gynecologic cancers , 2021, Cell reports. Medicine.

[12]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[13]  Chaoliang Tang,et al.  Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFβ/ALK1/Smad1/5 signaling pathway , 2020, Aging.

[14]  Min Wang,et al.  Long Noncoding RNA EBLN3P Promotes the Progression of Liver Cancer via Alteration of microRNA-144-3p/DOCK4 Signal , 2020, Cancer management and research.

[15]  Shuxia Wang,et al.  CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR-182 , 2020, Cancer Cell International.

[16]  Yi-Fan Li,et al.  Comprehensive analysis of the lncRNA-associated competing endogenous RNA network in breast cancer , 2019, Oncology reports.

[17]  N. Peng,et al.  MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA , 2017, OncoTargets and therapy.

[18]  Shikai Liu,et al.  MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4. , 2017, Biochemical and biophysical research communications.

[19]  Tsuyoshi Saito,et al.  Rap1GAP inhibits tumor progression in endometrial cancer. , 2017, Biochemical and biophysical research communications.

[20]  R. Jiang,et al.  MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer , 2017, Annals of clinical biochemistry.

[21]  Olaf Wolkenhauer,et al.  MicroRNA–mRNA interactions in colorectal cancer and their role in tumor progression , 2015, Genes, chromosomes & cancer.

[22]  Xiaowei Wang,et al.  miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..

[23]  X. Wang,et al.  A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA , 2014, Oncogene.

[24]  Hsien-Da Huang,et al.  miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..

[25]  Sarah Geisler,et al.  RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts , 2013, Nature Reviews Molecular Cell Biology.

[26]  Pier Paolo Pandolfi,et al.  ceRNA cross-talk in cancer: when ce-bling rivalries go awry. , 2013, Cancer discovery.

[27]  Debora S. Marks,et al.  miRcode: a map of putative microRNA target sites in the long non-coding transcriptome , 2012, Bioinform..

[28]  Bahram Parvin,et al.  Morphometic analysis of TCGA glioblastoma multiforme , 2011, BMC Bioinformatics.

[29]  Jiayi Wang,et al.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.

[30]  B. Lü,et al.  The association between metabolic abnormality and endometrial cancer: a large case-control study in China. , 2010, Gynecologic oncology.

[31]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[32]  Huirong Shi,et al.  miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth. , 2017, American journal of cancer research.